Literature DB >> 19565302

Establishment of a human neonatal hepatocyte cell line.

Yvonne Reid1, Jaya P Gaddipati, Deepmala Yadav, Judy Kantor.   

Abstract

Hepatocytes are routinely used to generate and identify drug metabolites and hepatic toxicity. Primary cultures of human hepatocytes are the model cell of choice for most of these pharmacological and toxicological studies. However, major problems are encountered with primary liver cell cultures: the dwindling availability of viable livers, hepatocytes having a limited life span, the loss of liver-specific functions in culture, and the donor to donor variability. These limitations have created a significant need for an in vitro hepatocyte system, which has both the potential for use in toxicological and pharmaceutical studies as well as clinical applications. Ectopic expression of human telomerase reverse transcriptase (hTERT) is one of the major strategies used to develop immortalized cells. Immortalization of primary cells using hTERT allows retention of the original cellular characteristics and functions and avoids some of the genetic and phenotypic instabilities associated with using known oncogenes. In the present study, we developed a cell line from human neonatal hepatocytes by transduction with a recombinant retrovirus expressing the hTERT gene. Induction of stable expression of hTERT in the neonatal cells led to immortalization of these cells. The cell line was cultured continuously for more than 25 passages, equivalent to >25 population doublings, whereas the parental cells senesced within five passages. Analysis of telomerase activity as measured by telomeric repeat amplification protocol assay indicated elevated levels of telomerase activity in immortalized cells compared to the parental cells. These immortalized human hepatocytes cells maintained a normal diploid karyotype as well as the gene expression profile similar to that of human normal neonatal hepatocytes. The data suggest that these immortalized cells preserved some of the biological characteristics of hepatic progenitor cells and might be useful as an in vitro model for pharmacological and toxicity studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565302     DOI: 10.1007/s11626-009-9219-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  23 in total

1.  Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes.

Authors:  H Ise; N Sugihara; N Negishi; T Nikaido; T Akaike
Journal:  Biochem Biophys Res Commun       Date:  2001-07-13       Impact factor: 3.575

2.  Immortalization of human hepatocytes by temperature-sensitive SV40 large-T antigen.

Authors:  M Smalley; K Leiper; R Tootle; P McCloskey; M J O'Hare; H Hodgson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-03       Impact factor: 2.416

Review 3.  Hepatic stem cells: in search of.

Authors:  Maggie H Walkup; David A Gerber
Journal:  Stem Cells       Date:  2006-05-04       Impact factor: 6.277

4.  In situ hybridization studies on expression of albumin and alpha-fetoprotein during the early stage of neoplastic transformation in rat liver.

Authors:  R P Evarts; P Nagy; E Marsden; S S Thorgeirsson
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

5.  Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.

Authors:  Solveigh Krusekopf; Ivar Roots; Ullrich Kleeberg
Journal:  Eur J Pharmacol       Date:  2003-04-11       Impact factor: 4.432

6.  Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts.

Authors:  Dominique Mahieu-Caputo; Jean-Etienne Allain; Julie Branger; Aurore Coulomb; Jean-Paul Delgado; Marion Andreoletti; Sylvie Mainot; René Frydman; Philippe Leboulch; James P Di Santo; Frédérique Capron; Anne Weber
Journal:  Hum Gene Ther       Date:  2004-12       Impact factor: 5.695

7.  Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes.

Authors:  N Kobayashi; T Fujiwara; K A Westerman; Y Inoue; M Sakaguchi; H Noguchi; M Miyazaki; J Cai; N Tanaka; I J Fox; P Leboulch
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

8.  Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes.

Authors:  Tuan Huy Nguyen; Gang Mai; Peter Villiger; José Oberholzer; Patrick Salmon; Philippe Morel; Leo Bühler; Didier Trono
Journal:  J Hepatol       Date:  2005-07-05       Impact factor: 25.083

9.  Characterization of cells in the developing human liver.

Authors:  Silvia Nava; Magnus Westgren; Marie Jaksch; Annika Tibell; Ulrika Broomé; Bo-Göran Ericzon; Suchitra Sumitran-Holgersson
Journal:  Differentiation       Date:  2005-06       Impact factor: 3.880

10.  Identification of bipotential progenitor cells in human liver development.

Authors:  Y Haruna; K Saito; S Spaulding; M A Nalesnik; M A Gerber
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  8 in total

1.  Gene expression pattern of insect fat body cells from in vitro challenge to cell line establishment.

Authors:  Huan Zhang; Qian Meng; Ping Tang; Xuan Li; Wei Zhu; Guiling Zhou; Ruihao Shu; Jihong Zhang; Qilian Qin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-09-12       Impact factor: 2.416

2.  Transdifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors.

Authors:  Tomomi Kogiso; Hikaru Nagahara; Motoyuki Otsuka; Keiko Shiratori; Steven F Dowdy
Journal:  Hepatol Int       Date:  2013-03-13       Impact factor: 6.047

3.  Higher-order chromatin regulation and differential gene expression in the human tumor necrosis factor/lymphotoxin locus in hepatocellular carcinoma cells.

Authors:  Takehisa Watanabe; Ko Ishihara; Akiyuki Hirosue; Sugiko Watanabe; Shinjiro Hino; Hidenori Ojima; Yae Kanai; Yutaka Sasaki; Mitsuyoshi Nakao
Journal:  Mol Cell Biol       Date:  2012-02-21       Impact factor: 4.272

4.  Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.

Authors:  Eva Ramboer; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2015

5.  Sgo1 is a potential therapeutic target for hepatocellular carcinoma.

Authors:  Lyu-Han Wang; Chia-Jui Yen; Tian-Neng Li; Sabine Elowe; Wen-Ching Wang; Lily Hui-Ching Wang
Journal:  Oncotarget       Date:  2015-02-10

6.  Development and characterization of a new human hepatic cell line.

Authors:  Eva Ramboer; Bram De Craene; Joey De Kock; Geert Berx; Vera Rogiers; Tamara Vanhaecke; Mathieu Vinken
Journal:  EXCLI J       Date:  2015-07-28       Impact factor: 4.068

7.  Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability.

Authors:  Tim Ting-Chung Yen; Anderson Yang; Wen-Tai Chiu; Tian-Neng Li; Lyu-Han Wang; Yi-Hsuan Wu; Hui-Chen Wang; Linyi Chen; Wen-Ching Wang; Wenya Huang; Chien-Wen Chang; Margaret Dah-Tsyr Chang; Meng-Ru Shen; Ih-Jen Su; Lily Hui-Ching Wang
Journal:  Oncotarget       Date:  2016-04-26

Review 8.  Strategies for immortalization of primary hepatocytes.

Authors:  Eva Ramboer; Bram De Craene; Joery De Kock; Tamara Vanhaecke; Geert Berx; Vera Rogiers; Mathieu Vinken
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.